P ULMONARY ARTERIOVENOUS FISTULAS
may occur in persons with or without hereditary hemorrhagic telangiectasia, but the close relationship of these two diseases warrants consideration of both together.
Hereditary telangiectasia may involve nearly any organ of the body, and severe bleeding may occur. The condition, therefore, should be of interest to all medical practitioners.
Hereditary telangiectasia was first described by Babington' in 1865, but subsequent contributions by others have led to the common designation "Rendu-OslerWeber disease" in honor of these three authors. The disease manifests itself by forming tiny ruby lesions on the face, the nasal and buccal mucous membranes, the lips, the skin of the body and in the nail beds ( Fig. 1 ). Bleeding from these lesions is due to rupture of the fragile vascular membrane, and profuse hemorrhage may result from trivial injury. All of the bleeding factors remain normal. Epistaxis is unusually common among affected persons and is often severe and frequent. The fact that telangiectasia may occur in any organ of the body explains the unusual frequency of hematuria, melena, hemoptysis and cerebral vascular hemorrhage in persons with this disease.
Reports of hereditary telangiectasia that have been made in the literature concern nearly 300 families, and more than 50 per
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Diseases of the Chest dition remains unknown. The telangiectatic spots are actually tiny dilatations of the capillaries or true arteriovenous fistulas that blanch on slight pressure.
PULMONARY ARTERIOVENOUS FISTULA
Histologic Aspects-The first description of pulmonary arteriovenous fistula was that of Churton' in 1897, but the first case was not recognized clinically until 1938 when Smith and HortonS made the diagnosis, reporting the case in 1939. The first surgical resection4 was performed by Shenstone and Janes in 1940. To the present, not more than 300 cases have been described. Seventy per cent of the patients with pulmonary arteriovenous fistulas reported in the literature had cutaneous telangiectasia or epistaxis or both.' This finding indicates that pulmonary arteriovenous fistula is often a part of a generalized vascular dysplasia rather than a purely localized condition. The fistulas are seldom seen in children, but they have been found in the newborn. The two sexes are affected about equally. Arteriovenous fistulas may occur in one or both lungs, and in more than a third of the cases they are multiple. Dilated afferent arteries and efferent veins lead into and out of these lesions and may form a tangle of distended vessels. The sac itself is lined with endothelium and may be paper thin.
Clinical Aspects-Pulmonary arteriovenous fistulas should be looked for in every person who has telangiectasia or who is a member of a family having this disease whether he himself has any visible signs of it or not. Clinically, two distinct types of the disease are recognized: pulmonary arteriovenous fistulas may have the classic triad of cyanosis, polycythemia and clubbing of the fingers and toes, or these signs may be entirely absent.
Cyanosis is said to occur when approximately 25 to 30 per cent of the blood in the lesser circulation is shunted from the nght to the left side of the heart through the fistula. Polycythemia develops from the bone marrow response to the low oxygen tension of the arterial blood. This may result from one or more large fistulas or many small ones, too tiny to be seen in the roentgenogram. Because intracardiac and intravascular pressures proximal to the fistula are normal, cardiac output is usually normal, the electrocardiogram is usually normal, and the heart is seldom enlarged, although with severe degrees of oxygen desaturation some cardiac enlargement may be noted. Dye-dilution curves are distorted by short appearance times due to venoarterial shunt and selectively may help to exclude the presence of fistula in the other lung.' As a practical measure, dye-dilution curves are seldom indicated. There is no disturbance of over-all circulatory dynamics, as the blood pressure, pulse rate and circulation time are normal. When arteriovenous fistulas of the lesser circulation do cause cyanosis, polycythemia and clubbing, removal of the fistula will bring about disappearance of all these signs. This indicates that they are reversible phenomena. Should they fail to disappear after removal of the lesion, other fistulas undoubtedly remain.
Many patients with pulmonary arteriovenous fistula do not have cyanosis, polycythemia and clubbing. This may be because the shunt is insufficient to cause them, because the anemia from bleeding is too severe to permit them, or because the fistula is in the greater rather than the lesser circulation. A bruit often can be heard and a thrill felt in the vicinity of the lesion.
Clinical Laboratory Findings -In the cases of pulmonary arteriovenous fistula without symptoms or signs, all the laboratory studies may be normal. In those in whom bleeding is profuse, anemia may predominate. When secondary polycythemia results from low oxygen tension, the red cell mass and the blood volume increase, but the plasma volume remains normal. The erythrocyte count, concentration of hemoglobin and cell volume may become markedly elevated Roentgenology -Thoracic roentgenograms show these fistulas as rounded or lobulated, fairly well-defined densities connected to the hilar structures by broad tortuous linear shadows due to the dilated vessels ( Fig. 2A) . On fluoroscopy they often may be seen to pulsate and may become smaller with the Valsalva maneuver (expiration against a closed glottis), or larger with the Mueller test (deep inspiration against a closed glottis).
Tomography usually will demonstrate the lesion well enough to be diagnostic (Fig. 2B) . The definitive examination, of Diferential Diagnosis-A single fistula may resemble a nodular lesion from any cause, including primary or metastatic tumor. If a bruit is heard in the vicinity of the heart, the condition may be confused with valvular heart disease. The cyanotic type of pulmonary arteriovenous fistula must be distinguished from congenital cyanotic heart disease and from polycythemia Vera. It differs from polycythemia Vera because in that condition the spleen is enlarged, there is no clubbing, the leukocyte count is elevated, there are immature cells in the blood stream, and the oxygen saturation of the blood is normal. None of these is present in cases of pulmonary arteriovenous fistula. The polycythemia of pulmonary artenovenous fistula is similar to polycythemia of high altitude.
Complications -Serious complications may result from the fistula itself: ( 1 ) bacterial endocarditis or endarteritis with multiple abscesses; (2) rupture of the fistula causing massive hematothorax or hemoptysis, and (3) central nervous system disorders such as cerebral embolism or thrombosis and brain abscess. In 27 per cent of the first 78 cases of pulmonary arteriovenous fistula reported in the literature, complications involved the central nervous system.' In nine of the first 170 cases reported, brain abscess"as present.
As the subject of a previous article, Burchell, Good, Clagett and one of us (C.H.H.)' reported a study of a large family with hereditary hemorrhagic telangiectasia. A summary of that report follows :
In this family, there were 331 persons in six generations, some of whom are now Approximately 40 per cent were found to have telangiectasia; about an equal number of each sex was affected and both sexes had transmitted the disease.
Age proved to be an important factor. Although telangiectasia was seldom recognized in young children, the frequency rose with increasing years until more than 90 per cent of those more than 60 years old were found to be afflicted. This suggests that perhaps all of them have the diesase and that it will ultimately become manifest if they live long enough, but the geneticists state that no more than half of the family can be afflicted.
It has been said that the disease may become less frequent in successive generations, and if the average age of each generation is not taken into account, so it would appear. We found the important factor to be the age of the individuals rather than the generation into which one is born, for the frequency of recognizable telangiectasia increases with greater age.
The real reason for this study was to determine just how many of a large family with hereditary telangiectasia have pulmonary arteriovenous fistulas.
Routine roentgenograms of the thorax were made on 125 of these persons, and these revealed that eight of them had arteriovenous fistulas, an incidence of 6.4 per cent of those surveyed roentgenographically. None of these eight had symptoms referable to the fistulas which were discovered only by routinely taking roentgenograms. In addition to these eight, we discovered that six other members of the family had pulmonary arteriovenous fistulas. The diagnosis was confirmed by history, by medical and surgical reports from elsewhere, and two of these six were seen at the clinic by one of us. All of these six came to medical attention because of symptoms and signs of the fistula. The total of 14 patients with fistula, therefore, represents 6.1 per cent of the entire group of 231 persons studied. In other words, a member of this family has about one chance in 15 of having a fistula, and a member who has telangiectasia has one chance in six of having a fistula. As would be expected, all of the members of the family with fistula had telangiectasia. Of the ten whom we were privileged to examine, seven had a bruit audible over the fistula.
Since publication of this report,' we have found two more members of this family who haue pulmonary arteriovenous fistula, making 16 in all.
The only effective treatment of pulmonary arteriovenous fistula is necessarily surgical removal of the fistula as all medical measures have proved of no value.
Because patients with this condition and opportunities to follow them halre been so few, the indications for operation are not well defined. M' e think that not all lesions require surgical treatment, at least not at the time of discovery, but they should be removed if the fistula is enlarging, if the patient has cyanosis and polycythemia, or if there is evidence of hemorrhage from the fistula, either hemoptysis or hematothorax. Maybe we err on the side of conservatism, and the serious complications among the cases studied would suggest this to be true, but for the present, we are reluctant to advise resection for the asymptomatic small lesions. Resection in some cases has been followed, according to reports, by the development of new fistulas in other parts of the same or the other lung and these may require resection. Because of that possibility and for other obvious reasons, the surgeon should conserve as much pulmonary tissue as possible in carrying out the operation; in other words, he should remove only the lesion itself and not the lung. We have studied all the cases of pulmonary arteriovenous fistulas that have been seen at the Mayo Clinic since the first case in 1938. There are 35 of them (Table I ) . In every case the lesion was clearly demonstrated roentgenographically and was diagnostic, or the lesion was proved by other means. Eleven of these 35 patients are members of the family with hereditary telangiectasia previously described, but five of the 16 patients with fistula in that family are not included in the 35 because they were not seen at the Mayo Clinic. Seventeen of our 35 (49 per cent) patients with pulmonary arteriovenous fistula had a family history of hemorrhagic telangiectasia and 23 of the 35 (66 per cent) were found to have telangiectasia on examination at the clinic.
The ages of these patients at the time of discovery of their fistulas varied from four to 64 years. Twenty-one were women. Sixteen were cyanotic and ten had polycythemia ( 16.0 gm. of hemoglobin or more per 100 ml. of blood). The highest value for hemoglobin recorded was 24.1 gm., and the next highest, 22.4 gm., was recorded in two cases. Two patients had hematocrit readings of 78 per cent. Oxygen saturation studies were performed on 16 patients and in 12 of these the degree of desaturation was significant (Table 2) .
Dye-dilution studies were done on two patients and curves were diagnostic of pulmonary arteriovenous fistula in both. In 20 patients a bruit was heard near the lesion.
Ten of the patients had more than one fistula. A four-year-old girl and a ten-yearold boy had multiple diffuse bilateral arteriovenous fistulas (Fig. 4) ; one patient had many fistulas in the left lower lobe; one had eight fistulas in both lungs; two had three, and four had two fistulas.
Fifteen of the patients had symptoms referable to the central nervous system that could have been and probably were associated with the telangiectasia or fistula.
Eight had significant bleeding from organs other than the nose, definitely or probably associated with the vascular disorder.
Nineteen of these patients have had surgical explorations of the lesions ( 18 of them at the Mayo Clinic). All were succes~fully removed except in the case of the fouryear-old girl who had diffuse bilateral aneurysms only a part of which could be removed. No recurrences are known in any of the 18 cases in which resection was done successfully.
In conclusion then it may be said that hereditary hemorrhagic telangiectasia is a rather formidable disease, and that it is important to recognize it and important to understand it. One of its more serious complications is pulmonary arteriovenous fistula, a dangerous condition present in one of every 15 members of the family studied. Although a majority of the arteriovenous fistulas of the lung have been found in patients afflicted with hereditary hemorrhagic telangiectasia, this is not always so.
The complications of the arteriovenous fistula itself are of such frequency and severity that surgical resection should be considered, though not necessarily carried out, in all cases. 
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Every person in a family with hereditary telangiectasia should know of the disease, should understand its importance, and should have periodic roentgenograms of the thorax to detect pulmonary arteriovenous fistulas. Furthermore, every person marrying into a family having hereditary hemorrhagic telangiectasia should be informed of the disease and should understand its implications before marriage.
Thirty-five cases of pulmonary arteriovenous fistula have been encountered a t the Mayo Clinic since the first case was recognized in 1938; these are reported here.
Se concluye que la telangiectasia hemorrigica hereditaria es una enfermedad formidable que debe reconocerse y que es importante que se comprenda Una de sus complicaciones mAs serias es la fistula arteriovenosa pulmonar, peligrosa afecci6n que se encontr6 en 1 de cada 15 miembros de la familia estudiada. Aunque la mayoria de las fistulas arteriovenosas del pulm6n se encontraron en personas afectadas por telangiectasia hemorriigica familiar, no siempre fue asl.
Las complicaciones de la fistula arteriovenosa por si mismas son de tal frecuencia y gravedad que la resecci6n quirfirgica debe considerarse, aunque no necesariamente ha de practicarse en todos 10s casos.
Toda persona en una familia con telangiectasia hereditaria debe conocer la enfermedad y comprender su importancia y debe sujetarse a roentgenogramas peri6dicos del t6rax para descubrir las fistulas pulmonares arteriovenosas. M i s afin, toda persona que contraiga matrimonio con otra que tenga antecedentes familiares de telangiectasia hemorriigica heredrtaria debe ser informada y debe comprender las repercusiones que eso tenga, antes del matrimonio.
Se 
